STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

13.12.2013 16:04

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Montanaro Asset Management Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 10 December 2013, that on 5 December 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.78% (562,565 voting rights). Montanaro Asset Management Limited has notified us that these voting rights of 4.78% (562,565 voting rights) are attributable to Montanaro European Smaller Companies PLC pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG.

13.12.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at and

Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
End of Announcement DGAP News-Service